Details
Cardiac amyloidosis can occur in two main forms: wild-type and hereditary. New treatment options are now available for both forms, including:
TTR stabilizers
TTR silencers
These treatments work in different ways and are delivered differently, making it important for patients and health care providers to have treatment options that fit individual needs.
Learn more: https://bit.ly/4oxG733